Digital From R&D to ROI: AI’s impact on pharma commercialisation AI in pharma commercialisation is transforming patient and healthcare provider engagement, streamlining regulatory reviews, and developing hyper-informed treatment pricing models, despite current scaling challenges.
News RNAi biotech City hauls in $200m in upsized IPO City Therapeutics has finalised its IPO, raising $200 million for a pipeline of RNA interference therapies headed by a novel anticoagulant.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
